Gandon Y, Brunet F, Guyader D, Brissot P, Carsin M, Simon J
Ann Radiol (Paris). 1989;32(4):267-72.
In this preliminary study, the authors studies MR imaging in four patients with malignant hepatic tumours before and after intravenous injection of 20 mumols/kg of superparamagnetic iron oxide (SIO). They obtained spin-echo sequences (SE 500/28/4, SE 2 000/28, 56/2) before and after injection and systematically compared the results with ultrasonography and computed tomography data. In every case, superparamagnetic iron oxide (SIO) resulted in a marked decrease in T2 and consequently in the signal of healthy hepatic and splenic tissue, considerably improving the visualisation of malignant lesions which remained unchanged. If the detectability of lesions is considered to depend on the contrast obtained between tumours and healthy tissue, these preliminary results are very promising.
在这项初步研究中,作者对4例恶性肝肿瘤患者在静脉注射20微摩尔/千克超顺磁性氧化铁(SIO)前后进行了磁共振成像(MR)研究。他们在注射前后获取了自旋回波序列(SE 500/28/4、SE 2000/28、56/2),并系统地将结果与超声检查和计算机断层扫描数据进行了比较。在每种情况下,超顺磁性氧化铁(SIO)均导致T2显著降低,进而使健康肝脏和脾脏组织的信号降低,显著改善了保持不变的恶性病变的可视化效果。如果认为病变的可检测性取决于肿瘤与健康组织之间获得的对比度,那么这些初步结果非常有前景。